[go: up one dir, main page]

ES2038642T3 - Tratamiento dermico de enfermedades vermiculares del gato con pracicuantel. - Google Patents

Tratamiento dermico de enfermedades vermiculares del gato con pracicuantel.

Info

Publication number
ES2038642T3
ES2038642T3 ES198787114168T ES87114168T ES2038642T3 ES 2038642 T3 ES2038642 T3 ES 2038642T3 ES 198787114168 T ES198787114168 T ES 198787114168T ES 87114168 T ES87114168 T ES 87114168T ES 2038642 T3 ES2038642 T3 ES 2038642T3
Authority
ES
Spain
Prior art keywords
cat
diseases
treatment
pracicuantel
dermic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787114168T
Other languages
English (en)
Inventor
Peter Dr. Andrews
Herbert Dr. Voege
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2038642T3 publication Critical patent/ES2038642T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

EL ANTEDICHO INVENTO SE TRATA DEL TRATAMIENTO DERMAL DE ENFERMEDADES DE CARCOMA DE GATOS CON PRAZIQUANTEL DE CANTIDAD DE CONSUMO DE 0,1-5 MG ACTIVADOR POR KG. DEL PESO ASI COMO MEDICAMENTOS APROPIADOS.
ES198787114168T 1986-10-11 1987-09-29 Tratamiento dermico de enfermedades vermiculares del gato con pracicuantel. Expired - Lifetime ES2038642T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863634755 DE3634755A1 (de) 1986-10-11 1986-10-11 Dermale behandlung von wurmerkrankungen der katze mit praziquantel

Publications (1)

Publication Number Publication Date
ES2038642T3 true ES2038642T3 (es) 1993-08-01

Family

ID=6311583

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787114168T Expired - Lifetime ES2038642T3 (es) 1986-10-11 1987-09-29 Tratamiento dermico de enfermedades vermiculares del gato con pracicuantel.

Country Status (7)

Country Link
US (2) US4988696A (es)
EP (1) EP0267404B1 (es)
JP (1) JPH0643309B2 (es)
AU (1) AU604759B2 (es)
CA (1) CA1323562C (es)
DE (2) DE3634755A1 (es)
ES (1) ES2038642T3 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5529600A (en) * 1999-06-18 2001-01-09 Bayer Aktiengesellschaft Anthelmintic compositions
US6429211B1 (en) * 2000-05-23 2002-08-06 Bayer Corporation Praziquantel compounds for treating diseases due to Sarcocystis Neospora Toxoplasma and Isospora
DE10117676A1 (de) * 2001-04-09 2002-10-10 Bayer Ag Dermal applizierbare flüssige Formulierungen zur Bekämpfung von parasitierenden Insekten an Tieren
US20030064941A1 (en) * 2001-05-21 2003-04-03 Pfizer Inc. Avermectin and praziquantel combination therapy
US7396819B2 (en) 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
US7234225B2 (en) * 2003-09-22 2007-06-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Method for manufacturing medical device having embedded traces and formed electrodes
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
KR100733385B1 (ko) 2006-07-07 2007-06-29 황도익 지붕판 고정장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2362539C2 (de) * 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4113867A (en) * 1973-12-17 1978-09-12 Merck Patent Gesellschaft Mit Beschrankter Haftung 2-acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
DE3619030A1 (de) * 1986-06-06 1987-12-10 Bayer Ag Topisch anwendbare zubereitungen

Also Published As

Publication number Publication date
US5093334A (en) 1992-03-03
EP0267404B1 (de) 1993-03-10
JPS6396127A (ja) 1988-04-27
AU7953487A (en) 1988-04-14
EP0267404A2 (de) 1988-05-18
EP0267404A3 (en) 1990-07-18
US4988696A (en) 1991-01-29
JPH0643309B2 (ja) 1994-06-08
AU604759B2 (en) 1991-01-03
DE3634755A1 (de) 1988-04-14
CA1323562C (en) 1993-10-26
DE3784628D1 (de) 1993-04-15

Similar Documents

Publication Publication Date Title
PT1162982E (pt) Utilizacao de oligonucleotidos estabilizados pata a preparacao de um meicamento com accao anti-tumor
SV1995000042A (es) Heteroaril-oxazolidinonas de 5 eslabones ref. le a 30523-sv
CY1111504T1 (el) Αζαδικυκλοαλκανια ως ρυθμιστες του ccr5
DE3779500D1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
ES2174989T3 (es) Pirido(3,2-e)pirazinonas con antiasmatica y procedimiento para su preparacion.
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
MX9301943A (es) Compuestos.
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
ES2072323T3 (es) Compuestos de piperidina y su preparacion y empleo.
IT7851429A0 (it) Medicamenti per trattare l'obesita'o ridurre il peso del corpo
FI863703L (fi) Glykocidderivat.
ATE102930T1 (de) Heterozyklische verbindungen, deren herstellung und medikamente diese enthaltend.
MX9307644A (es) Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo.
ES2038642T3 (es) Tratamiento dermico de enfermedades vermiculares del gato con pracicuantel.
ATE100320T1 (de) Verwendung von thromboxan-a2-rezeptorantagonisten zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von hautkrankheiten.
CO4700426A1 (es) Ligandos especificos del neuropeptido y1
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
NO302523B1 (no) Heterosykliske forbindelser, farmasöytiske preparater som omfatter dem, og anvendelse av forbindelsene for fremstilling av medikamenter
BG99054A (en) Mycobacterium vaccae for the treatment of continuous autoimmune conditions
ES2061770T3 (es) Antibioticos tan-1057.
FR2376660A1 (fr) Medicament a base d'alkannine, de shikonine ou de derives de ces substances, soignant les lesions cutanees de diverses origines
SV1996000008A (es) Uso de amidas de acido fenilciclohexilcarboxilicos
DK578887A (da) Antihypertensiva
ITMI921556A1 (it) Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 267404

Country of ref document: ES